Green Cross Health Past Earnings Performance
Past criteria checks 1/6
Green Cross Health's earnings have been declining at an average annual rate of -3.1%, while the Consumer Retailing industry saw earnings declining at 0.5% annually. Revenues have been declining at an average rate of 3.8% per year. Green Cross Health's return on equity is 9.6%, and it has net margins of 2.4%.
Key information
-3.1%
Earnings growth rate
-3.1%
EPS growth rate
Consumer Retailing Industry Growth | 12.4% |
Revenue growth rate | -3.8% |
Return on equity | 9.6% |
Net Margin | 2.4% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Here's Why Green Cross Health (NZSE:GXH) Has A Meaningful Debt Burden
Jul 24Little Excitement Around Green Cross Health Limited's (NZSE:GXH) Earnings As Shares Take 29% Pounding
Jun 27There May Be Some Bright Spots In Green Cross Health's (NZSE:GXH) Earnings
Jun 06Green Cross Health (NZSE:GXH) Will Pay A Smaller Dividend Than Last Year
Jun 05Green Cross Health Limited's (NZSE:GXH) Share Price Is Matching Sentiment Around Its Earnings
Dec 24Green Cross Health (NZSE:GXH) Has Announced That Its Dividend Will Be Reduced To NZ$0.0294
Dec 03Green Cross Health (NZSE:GXH) Is Paying Out A Dividend Of NZ$0.0412
Nov 28Capital Allocation Trends At Green Cross Health (NZSE:GXH) Aren't Ideal
May 04Green Cross Health (NZSE:GXH) Share Prices Have Dropped 58% In The Last Five Years
Mar 14Is Green Cross Health Limited (NZSE:GXH) Popular Amongst Insiders?
Feb 12Has Green Cross Health (NZSE:GXH) Got What It Takes To Become A Multi-Bagger?
Jan 28Is Green Cross Health Limited's (NZSE:GXH) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Jan 13Does Green Cross Health (NZSE:GXH) Have A Healthy Balance Sheet?
Dec 29Would Shareholders Who Purchased Green Cross Health's (NZSE:GXH) Stock Five Years Be Happy With The Share price Today?
Dec 14We Think Green Cross Health's (NZSE:GXH) Statutory Profit Might Understate Its Earnings Potential
Nov 29Revenue & Expenses Breakdown
How Green Cross Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 514 | 12 | 3 | 0 |
30 Jun 24 | 509 | 12 | 4 | 0 |
31 Mar 24 | 504 | 12 | 4 | 0 |
30 Sep 23 | 496 | 14 | 4 | 0 |
30 Jun 23 | 495 | 14 | 4 | 0 |
31 Mar 23 | 494 | 15 | 3 | 0 |
30 Sep 22 | 416 | 18 | 1 | 0 |
30 Jun 22 | 447 | 19 | 1 | 0 |
31 Mar 22 | 478 | 20 | 0 | 0 |
31 Dec 21 | 637 | 21 | 1 | 0 |
30 Sep 21 | 603 | 18 | 2 | 0 |
30 Jun 21 | 587 | 17 | 2 | 0 |
31 Mar 21 | 570 | 17 | 2 | 0 |
31 Dec 20 | 570 | 16 | 2 | 0 |
30 Sep 20 | 570 | 15 | 2 | 0 |
30 Jun 20 | 569 | 14 | 3 | 0 |
31 Mar 20 | 569 | 13 | 4 | 0 |
31 Dec 19 | 564 | 14 | 8 | 0 |
30 Sep 19 | 560 | 15 | 13 | 0 |
30 Jun 19 | 564 | 16 | 17 | 0 |
31 Mar 19 | 567 | 16 | 21 | 0 |
31 Dec 18 | 564 | 16 | 21 | 0 |
30 Sep 18 | 561 | 15 | 21 | 0 |
30 Jun 18 | 549 | 15 | 21 | 0 |
31 Mar 18 | 537 | 16 | 21 | 0 |
31 Dec 17 | 523 | 17 | 20 | 0 |
30 Sep 17 | 509 | 18 | 20 | 0 |
30 Jun 17 | 498 | 19 | 20 | 0 |
31 Mar 17 | 488 | 20 | 20 | 0 |
31 Dec 16 | 480 | 19 | 20 | 0 |
30 Sep 16 | 472 | 19 | 20 | 0 |
30 Jun 16 | 460 | 18 | 19 | 0 |
31 Mar 16 | 448 | 17 | 18 | 0 |
31 Dec 15 | 424 | 16 | 3 | 0 |
30 Sep 15 | 401 | 16 | -12 | 0 |
30 Jun 15 | 362 | 15 | 1 | 0 |
31 Mar 15 | 322 | 14 | 15 | 0 |
31 Dec 14 | 294 | 15 | 42 | 0 |
30 Sep 14 | 266 | 15 | 69 | 0 |
30 Jun 14 | 262 | 15 | 68 | 0 |
31 Mar 14 | 258 | 15 | 67 | 0 |
31 Dec 13 | 255 | 15 | 67 | 0 |
Quality Earnings: GXH has high quality earnings.
Growing Profit Margin: GXH's current net profit margins (2.4%) are lower than last year (2.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GXH's earnings have declined by 3.1% per year over the past 5 years.
Accelerating Growth: GXH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: GXH had negative earnings growth (-10.6%) over the past year, making it difficult to compare to the Consumer Retailing industry average (-5.9%).
Return on Equity
High ROE: GXH's Return on Equity (9.6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/25 13:49 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Green Cross Health Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Hayden Brown | Jarden NZ |